Amphastar Pharmaceuticals Inc (AMPH)
41.25
-0.77
(-1.83%)
USD |
NASDAQ |
Apr 30, 16:00
41.22
-0.02
(-0.06%)
After-Hours: 20:00
Amphastar Pharmaceuticals Revenue (TTM): 644.40M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 644.40M |
September 30, 2023 | 601.31M |
June 30, 2023 | 540.89M |
March 31, 2023 | 518.64M |
December 31, 2022 | 498.99M |
September 30, 2022 | 484.85M |
June 30, 2022 | 476.92M |
March 31, 2022 | 455.12M |
December 31, 2021 | 437.77M |
September 30, 2021 | 412.80M |
June 30, 2021 | 384.04M |
March 31, 2021 | 368.18M |
December 31, 2020 | 349.85M |
September 30, 2020 | 337.31M |
June 30, 2020 | 334.01M |
March 31, 2020 | 327.26M |
December 31, 2019 | 322.36M |
September 30, 2019 | 328.66M |
June 30, 2019 | 324.07M |
March 31, 2019 | 316.06M |
December 31, 2018 | 294.67M |
Date | Value |
---|---|
September 30, 2018 | 265.38M |
June 30, 2018 | 247.75M |
March 31, 2018 | 241.90M |
December 31, 2017 | 240.18M |
September 30, 2017 | 243.32M |
June 30, 2017 | 249.62M |
March 31, 2017 | 252.47M |
December 31, 2016 | 255.16M |
September 30, 2016 | 268.53M |
June 30, 2016 | 268.18M |
March 31, 2016 | 254.00M |
December 31, 2015 | 251.52M |
September 30, 2015 | 230.48M |
June 30, 2015 | 226.33M |
March 31, 2015 | 221.48M |
December 31, 2014 | 210.46M |
September 30, 2014 | 209.46M |
June 30, 2014 | 209.07M |
March 31, 2014 | 222.59M |
December 31, 2013 | 229.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
322.36M
Minimum
Dec 2019
644.40M
Maximum
Dec 2023
428.81M
Average
412.80M
Median
Sep 2021
Revenue (TTM) Benchmarks
Eli Lilly and Co | 34.12B |
Dentsply Sirona Inc | 3.965B |
Pacira BioSciences Inc | 674.98M |
Organon & Co | 6.263B |
NovaBay Pharmaceuticals Inc | 14.73M |